CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome.

MLA

Pagnotta, Sara, et al. “CAPE and Its Synthetic Derivative VP961 Restore BACH1/NRF2 Axis in Down Syndrome.” Free Radical Biology & Medicine, vol. 183, Apr. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2022.03.006.

APA

Pagnotta, S., Tramutola, A., Barone, E., Di Domenico, F., Pittalà, V., Salerno, L., Folgiero, V., Caforio, M., Locatelli, F., Petrini, S., Butterfield, D. A., & Perluigi, M. (2022). CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome. Free Radical Biology & Medicine, 183, 1–13. https://doi.org/10.1016/j.freeradbiomed.2022.03.006

Chicago

Pagnotta, Sara, Antonella Tramutola, Eugenio Barone, Fabio Di Domenico, Valeria Pittalà, Loredana Salerno, Valentina Folgiero, et al. 2022. “CAPE and Its Synthetic Derivative VP961 Restore BACH1/NRF2 Axis in Down Syndrome.” Free Radical Biology & Medicine 183 (April): 1–13. doi:10.1016/j.freeradbiomed.2022.03.006.